Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

Stopped early · Phase 2

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.

Key facts

Study ID

NCT00704782

Run by

Medivation, Inc.

People needed

50

Starts

2008-04-01

Expected to finish

2010-08-01

Last updated by the study team

2015-12-10

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Alzheimer's disease
• On donepezil (Aricept)
• Caregiver who cares for the patient at least 5 days per week

You may not qualify if…

• Unstable medical illnesses or significant hepatic or renal disease
• Other primary psychiatric or neurological disorders

Where it is running

• Xenoscience, Inc. — Phoenix, Arizona, United States
• Banner Alzheimer's Institute — Phoenix, Arizona, United States
• Barrow Neurological Institute — Phoenix, Arizona, United States
• Sun Health Research Institute — Sun City, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.